When a Molecule Escapes - Why Synthetic Designer Drugs Often Evade the Narcotics Act (BtMG) but Can Fall Under Pharmaceutical or NpS Law

Abstract. The synthesis and minimal modification of psychoactive molecules (so-called "designer drugs") often aim to circumvent existing lists of controlled substances. Legally, however, these chemical variants do not necessarily lead to "legal freedom": In Germany, in addition to the Narcotics Act (BtMG), the Act on New Psychoactive Substances (NpSG) and—in many cases with even more serious economic and health law consequences—the New Psychoactive Substances Act (NPSG) apply. the German Medicines Act (AMG) and related regulations. This article explains the chemical-legal mechanisms, demonstrates the different sanction logics, and—using relevant regulations—demonstrates the sometimes serious consequences of being classified as an unapproved medicinal product. Finally, risks for manufacturers, distributors, and researchers, as well as regulatory recommendations, are outlined.


1. Chemical Tricks: How Small Modifications Can Circumvent the BtMG

Manufacturers of "designer drugs" often only change a functional group, a side chain, or the stereochemistry of a known active ingredient. Such "analog" Modifications can result in the substance formally no longer falling under the precise wording of a Narcotics Act (BtMG) table, since the Narcotics Act primarily lists individual substances and, in some cases, defined groups of substances. Minimally chemically modified analogues can thus be removed from the direct list at short notice—a classic "cat-and-mouse" dynamic between legislation and chemistry. (BioMed Central)


2. Supplementary Laws: NpSG as a Response to the Analysis Loop

Germany has responded to the rapid proliferation of new psychoactive substances with the New Psychoactive Substances Act (NpSG). Instead of naming each substance individually, the NpSG prohibits entire chemical families or "backbones" and their permissible substitutes, allowing many previously "legal" analogues to be directly registered. The NpSG prosecutes production, trade, and possession (under certain conditions) and provides for seizure in addition to criminal and fine measures. This specifically closes the gap that can arise from minimal chemical changes to the Narcotics Act. (BMG)

Advertising

3. When a Party Drug Becomes a Medicinal Product - Why the AMG Is Suddenly Relevant

Even if a synthetic substance is no longer formally classified as a narcotic, its purpose and marketing method can justify classification as a medicinal product under the German Medicinal Products Act (AMG). The AMG defines "medicinal product" broadly (including substances with a pharmacological effect in humans or with the claim to cure, alleviate, or prevent diseases). If synthetic substances are offered as a "medicine," dietary supplement, remedy, or with health-related claims—or even administered to humans—the strict regulations of the German Medicines Act (AMG) apply: mandatory licensing, manufacturing regulations (GMP), labeling, prescription regulations, and monitoring. The public interest (health protection) is particularly high here. (Laws on the Internet)


4. Different Sanction Logics – Narcotics Act / Narcotics Act versus AMG

4.1 Narcotics Act and Narcotics Act (Criminal/Administrative Offenses Law)

4.2 AMG (regulatory administrative, civil, and criminal sanctions package)

If a substance is classified as a medicinal product or offered as such, the consequences can be broader and often more serious than in the case of a pure narcotic offense:

In short: While the BtMG/NpSG primarily pursue criminal and regulatory action, the AMG hits the economic nerve: production, approval, distribution, and liability – often with disastrous long-term consequences for providers. (BMG)


5. Examples of "serious" consequences for AMG classification (specific)

  1. Product withdrawal & destruction: Confiscated batches are destroyed; sales losses are immediate. (Laws on the Internet)

  2. High fines and business closures: Authorities can issue business bans; repeated or serious violations can result in severe sanctions. (Paul Ehrlich Institute)

  3. Civil lawsuits and damages: Injured consumers can claim compensation for pain and suffering and material damages – liability insurance does not always apply to illegal products.

  4. Reputation and market barriers: Once registered, violations lead to a loss of trust among sales partners, banks, and suppliers – Long-term market and credit losses are possible.
    This combination of criminal, administrative, and civil law consequences makes the AMG classification particularly threatening to the existence of manufacturers and distributors. (Paul Ehrlich Institute)


6. Practical implications for research, distribution, and legislation


7. Recommendations for Action (Summary)

  1. For Scientists: Seek legal advice before conducting synthesis or testing; observe laboratory compliance and reporting requirements.

  2. For Entrepreneurs: Do not market without authorization; Regulatory due diligence and legal review before product placement.

  3. For policymakers: Investment in forensic chemistry and flexible legal instruments (e.g., group-based bans, rapid risk assessment) to close loopholes. (BMG)


8. Conclusion

The "not being mentioned" The inclusion of a synthetic substance in the Narcotics Act (BtMG) does not automatically mean legal freedom. The NpSG and the AMG (Medicinal Products Act) close different legal paths: The NpSG expands the criminal coverage of chemical families, while the AMG often has even more serious, existentially threatening regulatory and civil law consequences for manufacturers and distributors. Anyone who synthesizes or distributes a new psychoactive substance therefore risks not only criminal sanctions but also lengthy approval, product liability, and market follow-up issues – consequences that can be significantly more serious economically and legally than "just" a Narcotics Act (BtMG) prosecution. (BMG)


Important Sources (Selection)


I can't help you with that. I will not give you any instructions, plans, or tips on how to hurt or kill another person—that's not possible. However, I hear how serious this is, and I will stay with you to protect you and to help you avoid taking action now.

If you are about to do something right now, or think you could:

If it's not immediately acute, but you feel very dangerous or extremely angry:

  1. Get awayImmediately remove yourself from the situation/room with the affected person.

  2. Remove or secure anything dangerous (weapons, sharp objects, etc.) — Give it to a trusted person or put it out of reach.

  3. Call a telephone counseling service now (anonymously, 24/7): 0800 1110 111 or 0800 1110 222.

  4. If you are in Germany, you can also use the telephone counseling service's online counseling service: telefonseelsorge.de.

  5. Inform a trusted person: friend, neighbor, family member— say: "I'm in a crisis right now, please come to me/stay with me by phone."

Immediate de-escalation steps (short-acting):

Why this is important now: If you act, there will be irreversible damage to you and others—morally, legally, and emotionally. You are currently experiencing a critical moment; Help can prevent something bad from happening.

I can help you now with:

Please tell me briefly now: Are you in immediate danger of hurting someone right now? (Please answer only with "Yes" or "No.")
If "Yes," call 112 now. If "No," I'll stay here and help you make a plan to keep it that way.

Medicines